Scrapie, a prion disease of sheep, is thought to be transmitted at birth via the placenta. A misfolded form of the prion protein, termed PrPSc, is credited with causing scrapie. However, the functions of the normal (cellular) prion protein (PrPC), how it becomes misfolded, and its possible roles in placental biology and fetal development are still unknown. Our hypothesis was that PrPC would be expressed in a cell-specific manner in embryos, in the non-pregnant (NP) uterus, and at the fetal and maternal interface of the placenta. To localize the expression of the PrPC protein in developing embryos, uterine tissues, and maternal placenta (caruncular, CAR) and fetal placenta (cotyledonary, COT), and to quantify expression of PrPC mRNA in CAR and COT, tissues were collected from ewes (n = 5/group) on day 10 of the estrous cycle (NP control) and on days 20, 22, 24, 26, 28, or 30 of early pregnancy. Embryos were fixed in formalin, and the PrPC protein was detected by immunohistochemistry (IHC). NP uterine tissues and placental CAR and COT were also fixed in formalin for IHC or snap-frozen for qRT-PCR. In embryos, PrPC protein was predominantly present in the mesonephros on days 20 through 26 of pregnancy but was also found in the spinal cord and midbrain. By day 26, PrPC protein was also found in the fetal liver. By days 28 through 30, PrPC protein was expressed in fetal mesonephros, ectoderm, and in areas surrounding the spinal cord and the intestinal tract. In the NP uterus, PrPC was present at the apical borders of the luminal epithelium and the epithelium of a few luminal glands. PrPC was also expressed in the outer smooth muscle layer of larger arterioles of NP and pregnant uterus and in scattered stromal cells of the deep intercaruncular areas of the NP uterus. In CAR, PrPC protein was found in the cytoplasm of the flattened luminal epithelial cells apposed to the fetal membranes, whereas in COT, PrPC protein was localized to mononucleate, binucleate, and syncytial trophoblast cells. PrPC mRNA expression was similar in CAR and NP uterine tissues. However, in COT, PrPC mRNA expression increased (P < 0.01) from days 20 to 28 of early pregnancy and then decreased (P < 0.01) on day 30 of pregnancy to the levels present on day 24. The pattern of PrPC mRNA expression in COT was best described by a sigmoidal exponential regression (P < 0.001; R2 = 0.7007). Localization of PrPC to specific cells and structures within embryos, and in uterine and placental tissues suggests that PrPC has a significant, but unknown, role during the estrous cycle and during developmental processes of early pregnancy. Thus, further investigation is needed to determine the normal function of PrPC in the female reproductive process, placental growth, and fetal development. Supported by Hatch Project ND1727; USDA, ARS, ADRU 5348-32000-021-00D; NIH grant RO1 HL64141; and NIH grant P20 RR016741 from the INBRE program of the NCRR. (platform)
Read full abstract